Home » Archives for oravax

oravax

Israel21c: Israeli oral COVID vaccine heads to Mexico, aims to fast-track approval

  • by

Oramed’s Oravax Medical and Genomma Lab Internacional announce joint venture to develop and commercialize vaccine for Latin America. By Abigail Klein Leichman  NOVEMBER 23, 2021, 10:56 AM Current Covid-19 vaccines are delivered via a shot in the arm – nobody’s favorite way to receive any medication – and must be… Read More »Israel21c: Israeli oral COVID vaccine heads to Mexico, aims to fast-track approval

Bloomberg: Oramed to Start Oral Covid-19 Vaccine Trial in South Africa

  • by

Oramed Pharmaceuticals Inc. won approval to run an initial clinical trial for its orally delivered Covid-19 vaccine candidate in South Africa. The U.S.-listed company has been given permission by the South African Health Regulatory Products Authority to start enrolling patients in Phase 1 of tests, it said in a… Read More »Bloomberg: Oramed to Start Oral Covid-19 Vaccine Trial in South Africa

Oramed Announces Oravax’s Oral COVID-19 Vaccine Has Received South African Approval to Initiate Phase 1 Trial

  • by

NEW YORK, October 29, 2021 – Oramed Pharmaceuticals Inc. (Nasdaq/TASE: ORMP) (www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, today announced that its majority-owned subsidiary, Oravax Medical Inc. (www.ora-vax.com), has received clearance from the South African Health Products Regulatory Authority to commence… Read More »Oramed Announces Oravax’s Oral COVID-19 Vaccine Has Received South African Approval to Initiate Phase 1 Trial